Unlock stock picks and a broker-level newsfeed that powers Wall Street.

3 Indian Exchange Stocks Estimated To Be Up To 40.6% Undervalued

In This Article:

In the last week, the Indian market has stayed flat, while the Communication Services sector gained 4.7%, contributing to an impressive 45% rise over the past year. With earnings forecasted to grow by 17% annually, identifying undervalued stocks can be a strategic move for investors looking to capitalize on potential market inefficiencies.

Top 10 Undervalued Stocks Based On Cash Flows In India

Name

Current Price

Fair Value (Est)

Discount (Est)

Everest Kanto Cylinder (NSEI:EKC)

₹187.06

₹306.08

38.9%

Apollo Pipes (BSE:531761)

₹604.85

₹1147.92

47.3%

Krsnaa Diagnostics (NSEI:KRSNAA)

₹713.40

₹1165.33

38.8%

Venus Pipes and Tubes (NSEI:VENUSPIPES)

₹2385.05

₹4380.61

45.6%

IOL Chemicals and Pharmaceuticals (BSE:524164)

₹442.00

₹762.32

42%

Updater Services (NSEI:UDS)

₹343.50

₹621.14

44.7%

Prataap Snacks (NSEI:DIAMONDYD)

₹857.75

₹1509.79

43.2%

Patel Engineering (BSE:531120)

₹53.64

₹91.76

41.5%

Artemis Medicare Services (NSEI:ARTEMISMED)

₹264.30

₹445.15

40.6%

Rajesh Exports (NSEI:RAJESHEXPO)

₹295.15

₹586.23

49.7%

Click here to see the full list of 31 stocks from our Undervalued Indian Stocks Based On Cash Flows screener.

Let's explore several standout options from the results in the screener.

Artemis Medicare Services

Overview: Artemis Medicare Services Limited manages and operates multi-specialty hospitals in India and internationally, with a market cap of ₹36.37 billion.

Operations: Artemis Medicare Services Limited generates revenue primarily from healthcare services, amounting to ₹8.92 billion.

Estimated Discount To Fair Value: 40.6%

Artemis Medicare Services appears undervalued based on cash flows, trading at ₹264.3, significantly below its estimated fair value of ₹445.15. Despite high debt levels, the company has shown robust earnings growth of 40% over the past year and is forecast to grow earnings by 45.4% annually, outpacing the Indian market's average growth rate. Recent quarterly results also reflect strong performance with increased revenue and net income compared to last year.

NSEI:ARTEMISMED Discounted Cash Flow as at Aug 2024
NSEI:ARTEMISMED Discounted Cash Flow as at Aug 2024

Fusion Finance

Overview: Fusion Finance Limited, a non-banking financial company with a market cap of ₹31.24 billion, provides microfinance lending services to women entrepreneurs in rural and semi-urban areas in India.

Operations: The company's revenue from micro financing activities amounts to ₹10.98 billion.

Estimated Discount To Fair Value: 18.5%

Fusion Finance is trading at ₹310.4, below its estimated fair value of ₹380.67, indicating it may be undervalued based on cash flows. The company's revenue is forecast to grow 29.4% per year, significantly outpacing the Indian market's 10% growth rate. However, earnings are expected to grow by 24.7%, and recent financial results show a net loss of ₹356.2 million for Q1 2024 compared to a net income of ₹1,204.6 million last year.

Waiting for permission
Allow microphone access to enable voice search

Try again.